There is a need for a company dedicated to improving the lives of those living with asthma. Altair Health is that company.

Over 300 million people suffer from asthma globally. In the U.S., 10 people die each day from asthma and according to the NIH, every one of these deaths is avoidable. At present, asthma has no cure and the treatment options are limited. For this reason, we have designed tools and a system that will revolutionize how asthma is managed.

Altair Health is a research and product development company with roots in behavioral science and an understanding of the psychological effects on the conditions we research. Our mission is to produce consumer-based products that can connect with and improve the lives of those living with autoimmune disorders including asthma, allergies and eczema. We have patents pending and multiple patents that we plan to file in the next 12-24 months. We have solutions for related conditions such as emphysema and a variety of autoimmune diseases. We have been researching atopy and severe asthma for the past six years and continue to monitor the additional research and studies that are published. We use new research methods to deepen our understanding of the condition and we continue to develop technologies that could improve the lives of those living with asthma.

The bottom line is this: those living who these autoimmune diseases do not have to suffer. They deserve treatment options and tools that can help them to live normal, everyday lives. Altair Health is here for this purpose.

Altair Health provides the option to allow investors to invest in one specific product or to invest in the company as a whole. Please fill out the form below to learn more about the company and begin investing today.